Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FFPUX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,255
Award facts
- Contract value 100% obligated
- $2,255.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,255.46 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitive, non-set-aside award utilizes a firm fixed price contract type and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania.
This delivery order falls within AmerisourceBergen Drug Corp's comprehensive $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. Dupixent is a biologic medication used to treat conditions including eczema, asthma, and chronic rhinosinusitis, and its procurement supports the Defense Health Agency's pharmaceutical supply chain requirements. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial portfolio of federal medical supply contracts with DLA and regularly fulfills orders for specialty medications and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FFPUX?
SPE2DB25FFPUX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FFPUX worth?
The government has obligated $2,255 on SPE2DB25FFPUX.
Is contract SPE2DB25FFPUX an order under another contract?
Yes. SPE2DB25FFPUX is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFPUX competed?
The extent of competition for SPE2DB25FFPUX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award